申请人:Slassi Abdelmalik
公开号:US20090023711A1
公开(公告)日:2009-01-22
Compounds of Formula I or pharmaceutically acceptable salts or solvates thereof:
wherein Ar
1
, Ar
2
, A, X, Y, m, n and R
1
, R
2
, R
3
, R
4
and R
5
are as described in the specification, processes for their preparation, pharmaceutical formulations comprising them and their use in therapy, particularly in the therapy of neurological and psychiatric disorders associated with glutamate dysfunction.
公式I的化合物或其药学上可接受的盐或溶剂化物:其中Ar1,Ar2,A,X,Y,m,n和R1,R2,R3,R4和R5如说明书所述,其制备方法,包括它们的药物制剂以及它们在治疗中的应用,特别是在与谷氨酸功能障碍相关的神经系统和精神障碍的治疗中。